Murine models for study of lipoprotein metabolism and atherosclerosis.

le Witztum, J L
Foilsithe 1993

Cholesterol awareness--key to preventing coronary artery disease.

le Witztum, J L
Foilsithe 1993

Role of oxidized low density lipoprotein in atherogenesis.

le Witztum, J L, Steinberg, D
Foilsithe 1991

A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

le Curtiss, L K, Witztum, J L
Foilsithe 1983

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.

le Palinski, W, Miller, E, Witztum, J L
Foilsithe 1995

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

le Picard, S, Parthasarathy, S, Fruebis, J, Witztum, J L
Foilsithe 1992

Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.

le Houglum, K, Filip, M, Witztum, J L, Chojkier, M
Foilsithe 1990

Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig.

le Witztum, J L, Steinbrecher, U P, Fisher, M, Kesaniemi, A
Foilsithe 1983

Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

le Young, S G, Bertics, S J, Curtiss, L K, Witztum, J L
Foilsithe 1987

Efficient expression of retroviral vector-transduced human low density lipoprotein (LDL) receptor in LDL receptor-deficient rabbit fibroblasts in vitro.

le Miyanohara, A, Sharkey, M F, Witztum, J L, Steinberg, D, Friedmann, T
Foilsithe 1988

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

le Witztum, J L, Steinbrecher, U P, Kesaniemi, Y A, Fisher, M
Foilsithe 1984

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

le Steinbrecher, U P, Parthasarathy, S, Leake, D S, Witztum, J L, Steinberg, D
Foilsithe 1984

Lipolysis Produces Changes in the Immunoreactivity and Cell Reactivity of Very Low Density Lipoproteins

le Schonfeld, G., Patsch, W., Pfleger, B., Witztum, J. L., Weidman, S. W.
Foilsithe 1979

Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

le Parthasarathy, S, Steinbrecher, U P, Barnett, J, Witztum, J L, Steinberg, D
Foilsithe 1985

Probucol inhibits oxidative modification of low density lipoprotein.

le Parthasarathy, S, Young, S G, Witztum, J L, Pittman, R C, Steinberg, D
Foilsithe 1986

Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.

le Levy, R A, Ostlund, R E, Semenkovich, C F, Witztum, J L
Foilsithe 1986

Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipopr...

le Steinbrecher, U P, Witztum, J L, Kesaniemi, Y A, Elam, R L
Foilsithe 1983

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

le Stemme, S, Faber, B, Holm, J, Wiklund, O, Witztum, J L, Hansson, G K
Foilsithe 1995

Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis.

le Parthasarathy, S, Khoo, J C, Miller, E, Barnett, J, Witztum, J L, Steinberg, D
Foilsithe 1990

Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects.

le Reaven, P, Parthasarathy, S, Grasse, B J, Miller, E, Steinberg, D, Witztum, J L
Foilsithe 1993